|
AGPS expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.630100E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.206800E-04 |
| Normal-vs-Stage2 |
2.228200E-01 |
| Normal-vs-Stage3 |
9.265600E-01 |
| Normal-vs-Stage4 |
8.027800E-01 |
| Stage1-vs-Stage2 |
6.363400E-01 |
| Stage1-vs-Stage3 |
4.817400E-03 |
| Stage1-vs-Stage4 |
3.557900E-03 |
| Stage2-vs-Stage3 |
2.650600E-01 |
| Stage2-vs-Stage4 |
1.861170E-01 |
| Stage3-vs-Stage4 |
7.576400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.071900E-02 |
| Normal-vs-AfricanAmerican |
4.719900E-02 |
| Normal-vs-Asian |
4.061200E-01 |
| Caucasian-vs-AfricanAmerican |
5.63390000000163E-05 |
| Caucasian-vs-Asian |
7.991000E-01 |
| AfricanAmerican-vs-Asian |
5.855900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.740400E-01 |
| Normal-vs-Female |
2.335300E-03 |
| Male-vs-Female |
1.195660E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.624200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.315900E-03 |
| Normal-vs-Age(61-80Yrs) |
1.526790E-01 |
| Normal-vs-Age(81-100Yrs) |
5.643600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.398100E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.699800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.577400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.715820E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.994600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.866200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.412470E-02 |
| Normal-vs-Grade 2 |
6.783300E-04 |
| Normal-vs-Grade 3 |
1.386190E-01 |
| Normal-vs-Grade 4 |
3.395700E-02 |
| Grade 1-vs-Grade 2 |
6.395000E-01 |
| Grade 1-vs-Grade 3 |
2.156600E-01 |
| Grade 1-vs-Grade 4 |
8.837900E-04 |
| Grade 2-vs-Grade 3 |
2.768100E-02 |
| Grade 2-vs-Grade 4 |
8.41420000341486E-08 |
| Grade 3-vs-Grade 4 |
2.993000E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.23649995692676E-09 |
| Normal-vs-ccB subtype |
2.904800E-01 |
| ccA subtype-vs-ccB subtype |
5.81068526628314E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.640010E-02 |
| Normal-vs-N1 |
4.926800E-01 |
| N0-vs-N1 |
1.892760E-01 |
|
|
